This brand name is authorized in Hong Kong SAR China, Spain, Turkey.
The drug HIBOR contains one active pharmaceutical ingredient (API):
1
|
UNII
P59JKU02CE - BEMIPARIN SODIUM
|
|
Bemiparin is a LMWH obtained by depolymerization of heparin from porcine intestinal mucosa. Bemiparin has confirmed its antithrombotic activity and, at the recommended doses, it does not significantly prolong global clotting tests. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B01AB12 | Bemiparin | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 61907, 61908, 64164, 64165, 64166, 74793 |
| HK | Department of Health Drug Office | 53830, 53831, 53832, 53833, 53834 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699769950064, 8699769950071, 8699769950088, 8699769950095, 8699769950101, 8699769950118 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.